U.S. markets open in 8 hours 9 minutes

Cerevel Therapeutics Holdings, Inc. (CERE)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
37.57+1.09 (+2.99%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
MACD

MACD

Previous Close36.48
Open36.75
Bid0.00 x 1100
Ask0.00 x 900
Day's Range35.63 - 37.99
52 Week Range9.00 - 37.99
Volume1,631,412
Avg. Volume2,420,977
Market Cap5.443B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.62
Earnings DateNov 15, 2021 - Nov 19, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est33.00
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Cerevel Therapeutics Holdings,
    Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We CoverThis edition features digital adversiting and regulatory risk; our quarterly telecom outlook; new coverage of backup power leader Generac; and notes from Continental, Goldman Sachs, and Boston Beer.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more